1. Joseph W. S. Handbook of lower Extremity Infections. New York : Churchill Livingstone, 1990.

2. Mandell GI, Bennett JE, Dolin R. Principles and Practice of Infections Disease. 4th Ed. New York: Churchill Livingstone, 1995.

3. Echman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost - effectiveness analysis. JAMA 273:712, 1995.

4. Taylor LM Jr, Porter JM. The clinical course of diabetics who require emregent foot surgery because of infection or ischemia. J Vase Surg 6: 454, 1987.

5. Ragnarson-Tennvall G, Apelqvist J . Cost-effective management of diabetic foot ulcers. Pharmacoeconomics 12:42, 1997.

6. Wagner FW. The dysvascular foot: a system for diagbosis and treatment. Foot Ankle 2:64, 1981.

7. Shea JD. Pressure sores: classification and management. Clin Orthop 112:89, 1975.

8. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 35:528, 1996.

9. Pecoraro RE, Reiber GE. Classification of wounds in diabetic amputees. Wounds 2:65, 1990.

10. Regranex (bacaplermin) gel 0.01%, Product labeling, Ortho-McNeil Pharmaceutical, Raritan, NJ, Jan 1998.

11. Wieman TJ, Smiell JM, Su Y. Effficay and safety of topical gel formulation of recombinant human platlet-derived growth factor-BB (becaplermin) in patients with chronic neurtopathic diabetic ylcers. Diabets Care 21:822, 1998.

12. d,Hemecourt PA, Smiell JA, Hugill JV, et al . The effect of topically applied sodium carboxymethylcellulose gel on nonhealing lower extremity ulcers in patients with diabetes with diabetes. European Tissue Repair Meeting , August 1997.

13. Steed DL. Clinical evaluation of recopminant treatment of lower extremity diabetic ulcers. J VAsc Surg 21:71, 1995.